Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""SALMETEROL"" wg kryterium: Temat


Tytuł:
Fluticasone propionate/salmeterol 250/50 μg versus salmeterol 50 μg after chronic obstructive pulmonary disease exacerbation.
Autorzy:
Ohar JA; Wake Forest University Medical Center, 1 Medical Center Boulevard, Winston-Salem, NC, USA. .
Crater GD
Emmett A
Ferro TJ
Morris AN
Raphiou I
Sriram PS
Dransfield MT
Pokaż więcej
Źródło:
Respiratory research [Respir Res] 2014 Sep 24; Vol. 15, pp. 105. Date of Electronic Publication: 2014 Sep 24.
Typ publikacji:
Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Disease Progression*
Albuterol/*analogs & derivatives
Androstadienes/*administration & dosage
Bronchodilator Agents/*administration & dosage
Pulmonary Disease, Chronic Obstructive/*diagnosis
Pulmonary Disease, Chronic Obstructive/*drug therapy
Administration, Inhalation ; Aged ; Albuterol/administration & dosage ; Double-Blind Method ; Drug Combinations ; Female ; Fluticasone-Salmeterol Drug Combination ; Humans ; Male ; Middle Aged ; Salmeterol Xinafoate
Czasopismo naukowe
Tytuł:
Stimulus-selective regulation of human mast cell gene expression, degranulation and leukotriene production by fluticasone and salmeterol.
Autorzy:
Catalli A; National Institute for Nanotechnology, National Research Council, Edmonton, Alberta, Canada.
Karpov V; National Institute for Nanotechnology, National Research Council, Edmonton, Alberta, Canada.
Erdos LE; Northwestern University Feinberg School of Medicine, Allergy-Immunology Division, Chicago, Ilinois, United States of America.
Tancowny BP; Northwestern University Feinberg School of Medicine, Allergy-Immunology Division, Chicago, Ilinois, United States of America.
Schleimer RP; Northwestern University Feinberg School of Medicine, Allergy-Immunology Division, Chicago, Ilinois, United States of America.
Kulka M; National Institute for Nanotechnology, National Research Council, Edmonton, Alberta, Canada; Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta, Canada.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2014 May 12; Vol. 9 (5), pp. e96891. Date of Electronic Publication: 2014 May 12 (Print Publication: 2014).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Albuterol/*analogs & derivatives
Androstadienes/*pharmacology
Leukotrienes/*metabolism
Mast Cells/*drug effects
Mast Cells/*metabolism
Albuterol/pharmacology ; Cell Line ; Fluticasone ; Humans ; Salmeterol Xinafoate
Czasopismo naukowe
Tytuł:
Mixing time effects on the dispersion performance of adhesive mixtures for inhalation.
Autorzy:
Grasmeijer F; Department of Pharmaceutical Technology and Biopharmacy, University of Groningen, Groningen, The Netherlands. />Hagedoorn P
Frijlink HW
de Boer HA
Pokaż więcej
Źródło:
PloS one [PLoS One] 2013 Jul 02; Vol. 8 (7), pp. e69263. Date of Electronic Publication: 2013 Jul 02 (Print Publication: 2013).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Albuterol/*analogs & derivatives
Androstadienes/*chemistry
Chemistry, Pharmaceutical/*methods
Lactose/*chemistry
Administration, Inhalation ; Albuterol/administration & dosage ; Albuterol/chemistry ; Albuterol/pharmacokinetics ; Androstadienes/administration & dosage ; Androstadienes/pharmacokinetics ; Drug Carriers/chemistry ; Fluticasone ; Lasers ; Microscopy, Electron, Scanning ; Particle Size ; Salmeterol Xinafoate ; Solubility ; Time Factors ; X-Ray Diffraction
Czasopismo naukowe
Tytuł:
Health status in the TORCH study of COPD: treatment efficacy and other determinants of change.
Autorzy:
Jones PW; Department of Cardiac and Vascular Sciences, St George's Hospital, University of London, London, UK. />Anderson JA
Calverley PM
Celli BR
Ferguson GT
Jenkins C
Yates JC
Vestbo J
Spencer MD
Pokaż więcej
Corporate Authors:
TORCH investigators
Źródło:
Respiratory research [Respir Res] 2011 May 31; Vol. 12, pp. 71. Date of Electronic Publication: 2011 May 31.
Typ publikacji:
Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial
MeSH Terms:
Health Status*
Adrenergic beta-2 Receptor Agonists/*therapeutic use
Albuterol/*analogs & derivatives
Androstadienes/*therapeutic use
Bronchodilator Agents/*therapeutic use
Glucocorticoids/*therapeutic use
Pulmonary Disease, Chronic Obstructive/*drug therapy
Age Factors ; Aged ; Albuterol/therapeutic use ; Asia ; Disease Progression ; Double-Blind Method ; Drug Combinations ; Europe ; Female ; Fluticasone ; Fluticasone-Salmeterol Drug Combination ; Forced Expiratory Volume ; Health Status Indicators ; Humans ; Lung/drug effects ; Lung/physiopathology ; Male ; Middle Aged ; Predictive Value of Tests ; Pulmonary Disease, Chronic Obstructive/diagnosis ; Pulmonary Disease, Chronic Obstructive/mortality ; Pulmonary Disease, Chronic Obstructive/physiopathology ; Pulmonary Disease, Chronic Obstructive/psychology ; Quality of Life ; Risk Assessment ; Risk Factors ; Salmeterol Xinafoate ; Severity of Illness Index ; Surveys and Questionnaires ; Time Factors ; Treatment Outcome ; United States
Czasopismo naukowe
Tytuł:
The effect of inhaled salmeterol, alone and in combination with fluticasone propionate, on management of COPD patients.
Autorzy:
Mansori F; Department of Medicine, Medical School, Kermanshah University of Medical Sciences, Mashhad, Iran.
Nemat Khorasani A
Boskabady MH
Boskabady M
Pokaż więcej
Źródło:
The clinical respiratory journal [Clin Respir J] 2010 Oct; Vol. 4 (4), pp. 241-7.
Typ publikacji:
Comparative Study; Journal Article; Randomized Controlled Trial
MeSH Terms:
Adrenergic beta-2 Receptor Agonists/*administration & dosage
Albuterol/*analogs & derivatives
Androstadienes/*administration & dosage
Glucocorticoids/*administration & dosage
Pulmonary Disease, Chronic Obstructive/*drug therapy
Administration, Inhalation ; Aged ; Albuterol/administration & dosage ; Drug Combinations ; Fluticasone-Salmeterol Drug Combination ; Humans ; Male ; Middle Aged ; Pulmonary Disease, Chronic Obstructive/diagnosis ; Respiratory Function Tests ; Salmeterol Xinafoate ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Step-down from high dose fixed combination therapy in asthma patients: a randomized controlled trial.
Autorzy:
Papi A; Research Center on Asthma and COPD, University of Ferrara, Via Savonarola 9, 44100, Ferrara, Italy. />Nicolini G
Crimi N
Fabbri L
Olivieri D
Rossi A
Paggiaro P
Pokaż więcej
Źródło:
Respiratory research [Respir Res] 2012 Jun 25; Vol. 13, pp. 54. Date of Electronic Publication: 2012 Jun 25.
Typ publikacji:
Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Albuterol/*analogs & derivatives
Androstadienes/*administration & dosage
Asthma/*drug therapy
Asthma/*physiopathology
Beclomethasone/*administration & dosage
Adolescent ; Adult ; Aged ; Albuterol/administration & dosage ; Bronchodilator Agents/administration & dosage ; Drug Administration Schedule ; Drug Combinations ; Drug Therapy, Combination ; Female ; Fluticasone-Salmeterol Drug Combination ; Humans ; Male ; Middle Aged ; Prospective Studies ; Young Adult
Czasopismo naukowe
Tytuł:
Observational study of the outcomes and costs of initiating maintenance therapies in patients with moderate exacerbations of COPD.
Autorzy:
Dalal AA; GlaxoSmithKline, Research Triangle Park, 5 Moore Dr, Bide West, Durham, NC 27709, USA. />Shah MB
D'Souza AO
Lunacsek OE
Nagar SP
Crater GD
Pokaż więcej
Źródło:
Respiratory research [Respir Res] 2012 May 31; Vol. 13, pp. 41. Date of Electronic Publication: 2012 May 31.
Typ publikacji:
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Albuterol/*analogs & derivatives
Androstadienes/*economics
Androstadienes/*therapeutic use
Cholinergic Antagonists/*economics
Cholinergic Antagonists/*therapeutic use
Health Care Costs/*statistics & numerical data
Pulmonary Disease, Chronic Obstructive/*drug therapy
Pulmonary Disease, Chronic Obstructive/*economics
Albuterol/economics ; Albuterol/therapeutic use ; Drug Combinations ; Female ; Fluticasone-Salmeterol Drug Combination ; Humans ; Middle Aged ; Prevalence ; Pulmonary Disease, Chronic Obstructive/epidemiology ; Sympathomimetics/economics ; Sympathomimetics/therapeutic use ; Treatment Outcome ; United States
Czasopismo naukowe
Tytuł:
Combined fluticasone propionate and salmeterol reduces RSV infection more effectively than either of them alone in allergen-sensitized mice.
Autorzy:
Singam R; Division of Allergy and Immunology, Joy McCann Culverhouse Airway Disease Research Center, University of South Florida College of Medicine and James A, Haley VA Hospital, Tampa, FL, USA. />Jena PK
Behera S
Hellermann GR
Lockey RF
Ledford D
Mohapatra SS
Pokaż więcej
Źródło:
Virology journal [Virol J] 2006 May 23; Vol. 3, pp. 32. Date of Electronic Publication: 2006 May 23.
Typ publikacji:
Comparative Study; Journal Article
MeSH Terms:
Albuterol/*analogs & derivatives
Allergens/*immunology
Androstadienes/*administration & dosage
Androstadienes/*therapeutic use
Ovalbumin/*immunology
Respiratory Syncytial Virus Infections/*drug therapy
Albuterol/administration & dosage ; Albuterol/therapeutic use ; Animals ; Anti-Allergic Agents/administration & dosage ; Anti-Allergic Agents/therapeutic use ; Asthma/drug therapy ; Bronchoalveolar Lavage ; Bronchodilator Agents/administration & dosage ; Bronchodilator Agents/therapeutic use ; Drug Combinations ; Female ; Fluticasone ; Fluticasone-Salmeterol Drug Combination ; Lung/drug effects ; Lung/pathology ; Mice ; Mice, Inbred BALB C ; Respiratory Syncytial Virus Infections/immunology ; Salmeterol Xinafoate
Czasopismo naukowe
Tytuł:
Cost-effectiveness and cost-utility of beclomethasone/formoterol versus fluticasone propionate/salmeterol in patients with moderate to severe asthma.
Autorzy:
Gerzeli S; Department of Political and Social Sciences, University of Pavia, Pavia, Italy. />Rognoni C
Quaglini S
Cavallo MC
Cremonesi G
Papi A
Pokaż więcej
Źródło:
Clinical drug investigation [Clin Drug Investig] 2012 Apr 01; Vol. 32 (4), pp. 253-65.
Typ publikacji:
Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Albuterol/*analogs & derivatives
Androstadienes/*economics
Anti-Asthmatic Agents/*economics
Beclomethasone/*economics
Ethanolamines/*economics
Albuterol/economics ; Albuterol/therapeutic use ; Androstadienes/therapeutic use ; Anti-Asthmatic Agents/therapeutic use ; Asthma/drug therapy ; Asthma/economics ; Beclomethasone/administration & dosage ; Beclomethasone/therapeutic use ; Computer Simulation ; Cost-Benefit Analysis ; Drug Combinations ; Ethanolamines/administration & dosage ; Ethanolamines/therapeutic use ; Fluticasone-Salmeterol Drug Combination ; Formoterol Fumarate ; Humans ; Italy ; Markov Chains ; Models, Economic ; Quality-Adjusted Life Years ; Severity of Illness Index
Czasopismo naukowe
Tytuł:
Onset of action of formoterol versus salmeterol via dry powder inhalers in moderate chronic obstructive pulmonary disease: a randomized, placebo-controlled, double-blind, crossover study.
Autorzy:
Cazzola M; Unit of Respiratory Clinical Pharmacology, Department of Internal Medicine, University of Rome Tor Vergata, Rome, Italy. />Paggiaro P
Palange P
Bjermer L
Ausin P
Carlsson LG
Ekelund J
Lotvall J
Pokaż więcej
Źródło:
Clinical drug investigation [Clin Drug Investig] 2012 Mar 01; Vol. 32 (3), pp. 147-55.
Typ publikacji:
Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Albuterol/*analogs & derivatives
Bronchodilator Agents/*administration & dosage
Ethanolamines/*administration & dosage
Pulmonary Disease, Chronic Obstructive/*drug therapy
Adult ; Aged ; Aged, 80 and over ; Albuterol/administration & dosage ; Cross-Over Studies ; Double-Blind Method ; Dry Powder Inhalers ; Female ; Forced Expiratory Volume ; Formoterol Fumarate ; Humans ; Male ; Middle Aged ; Pulmonary Disease, Chronic Obstructive/physiopathology ; Salmeterol Xinafoate
Czasopismo naukowe
Tytuł:
Observational study on the impact of initiating tiotropium alone versus tiotropium with fluticasone propionate/salmeterol combination therapy on outcomes and costs in chronic obstructive pulmonary disease.
Autorzy:
Chatterjee A; Department of Internal Medicine, Wake Forest University School of Medicine, Medical Center Blvd, Winston-Salem, NC 27157, USA. />Shah M
D'Souza AO
Bechtel B
Crater G
Dalal AA
Pokaż więcej
Źródło:
Respiratory research [Respir Res] 2012 Feb 17; Vol. 13, pp. 15. Date of Electronic Publication: 2012 Feb 17.
Typ publikacji:
Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Albuterol/*analogs & derivatives
Androstadienes/*therapeutic use
Bronchodilator Agents/*therapeutic use
Pulmonary Disease, Chronic Obstructive/*drug therapy
Scopolamine Derivatives/*therapeutic use
Aged ; Albuterol/economics ; Albuterol/therapeutic use ; Androstadienes/economics ; Bronchodilator Agents/economics ; Disease Progression ; Drug Combinations ; Drug Therapy, Combination/economics ; Female ; Fluticasone-Salmeterol Drug Combination ; Humans ; Male ; Middle Aged ; Pulmonary Disease, Chronic Obstructive/economics ; Retrospective Studies ; Risk ; Scopolamine Derivatives/economics ; Tiotropium Bromide ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Identifying ligand binding conformations of the β2-adrenergic receptor by using its agonists as computational probes.
Autorzy:
Isin B; Department of Pathology, University of Pittsburgh, Pittsburgh, PA, USA. />Estiu G
Wiest O
Oltvai ZN
Pokaż więcej
Źródło:
PloS one [PLoS One] 2012; Vol. 7 (12), pp. e50186. Date of Electronic Publication: 2012 Dec 31.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Molecular Dynamics Simulation*
Adrenergic beta-2 Receptor Agonists/*metabolism
Albuterol/*analogs & derivatives
Receptors, Adrenergic, beta-2/*chemistry
Receptors, Adrenergic, beta-2/*metabolism
Albuterol/metabolism ; Allosteric Site ; Binding Sites ; Crystallography, X-Ray ; Humans ; Models, Molecular ; Nuclear Magnetic Resonance, Biomolecular ; Protein Binding ; Protein Conformation ; Salmeterol Xinafoate ; Thermodynamics
Czasopismo naukowe
Tytuł:
Relationship between the anti-inflammatory properties of salmeterol/fluticasone and the expression of CD4⁺CD25⁺Foxp3⁺ regulatory T cells in COPD.
Autorzy:
Yang L; Institute of Respiratory Diseases, the Second Hospital of the Third Military Medical University of China, 183 Xinqiao Street, Chongqing 400037, P. R. China.
Ma QL
Yao W
Zhang Q
Chen HP
Wang GS
Wang CZ
Pokaż więcej
Źródło:
Respiratory research [Respir Res] 2011 Oct 28; Vol. 12, pp. 142. Date of Electronic Publication: 2011 Oct 28.
Typ publikacji:
Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Albuterol/*analogs & derivatives
Androstadienes/*administration & dosage
Cytokines/*immunology
Pulmonary Disease, Chronic Obstructive/*drug therapy
Pulmonary Disease, Chronic Obstructive/*immunology
T-Lymphocytes, Regulatory/*immunology
Adult ; Aged ; Albuterol/administration & dosage ; Anti-Inflammatory Agents/administration & dosage ; Bronchodilator Agents/administration & dosage ; CD4 Antigens/immunology ; Female ; Fluticasone ; Forkhead Transcription Factors/immunology ; Gene Expression Regulation/drug effects ; Gene Expression Regulation/immunology ; Humans ; Interleukin-2 Receptor alpha Subunit/immunology ; Male ; Middle Aged ; Pulmonary Disease, Chronic Obstructive/pathology ; Salmeterol Xinafoate ; T-Lymphocytes, Regulatory/drug effects ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Formoterol and salmeterol induce a similar degree of β2-adrenoceptor tolerance in human small airways but via different mechanisms.
Autorzy:
Cooper PR; Department of Medicine, Airway Biology Initiative, University of Pennsylvania School of Medicine, Philadelphia, USA.
Kurten RC
Zhang J
Nicholls DJ
Dainty IA
Panettieri RA
Pokaż więcej
Źródło:
British journal of pharmacology [Br J Pharmacol] 2011 Jun; Vol. 163 (3), pp. 521-32.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Adrenergic beta-2 Receptor Agonists/*pharmacology
Albuterol/*analogs & derivatives
Bronchodilator Agents/*pharmacology
Ethanolamines/*pharmacology
Lung/*drug effects
Receptors, Adrenergic, beta-2/*metabolism
Albuterol/pharmacology ; Bronchoconstriction/drug effects ; Budesonide/pharmacology ; Carbachol/pharmacology ; Drug Tolerance ; Epithelial Cells/drug effects ; Epithelial Cells/physiology ; Formoterol Fumarate ; Humans ; In Vitro Techniques ; Lung/physiology ; Protein Transport ; Salmeterol Xinafoate
Czasopismo naukowe
Tytuł:
The Beta Agonist Lung Injury TrIal (BALTI)--prevention trial protocol.
Autorzy:
Perkins GD; University of Warwick, Warwick Medical School Clinical Trials Unit, Warwick CV4 7AL, UK. />Park D
Alderson D
Cooke MW
Gao F
Gates S
Lamb SE
Mistry D
Thickett DR
Pokaż więcej
Źródło:
Trials [Trials] 2011 Mar 15; Vol. 12, pp. 79. Date of Electronic Publication: 2011 Mar 15.
Typ publikacji:
Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Research Design*
Acute Lung Injury/*prevention & control
Adrenergic beta-2 Receptor Agonists/*administration & dosage
Albuterol/*analogs & derivatives
Esophagectomy/*adverse effects
Acute Lung Injury/etiology ; Acute Lung Injury/mortality ; Administration, Inhalation ; Albuterol/administration & dosage ; Double-Blind Method ; Drug Administration Schedule ; Elective Surgical Procedures ; Esophagectomy/mortality ; Humans ; Placebo Effect ; Quality of Life ; Respiration, Artificial ; Salmeterol Xinafoate ; Survival Rate ; Time Factors ; Treatment Outcome ; United Kingdom
Czasopismo naukowe
Tytuł:
Bias due to withdrawal in long-term randomised trials in COPD: evidence from the TORCH study.
Autorzy:
Vestbo J; Department of Cardiology and Respiratory Medicine, Hvidovre Hospital and University of Copenhagen, Hvidovre, Denmark. />Anderson JA
Calverley PM
Celli B
Ferguson GT
Jenkins C
Yates JC
Jones PW
Pokaż więcej
Źródło:
The clinical respiratory journal [Clin Respir J] 2011 Jan; Vol. 5 (1), pp. 44-9.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Patient Dropouts*
Randomized Controlled Trials as Topic*
Albuterol/*analogs & derivatives
Androstadienes/*therapeutic use
Bronchodilator Agents/*therapeutic use
Pulmonary Disease, Chronic Obstructive/*drug therapy
Albuterol/therapeutic use ; Bias ; Drug Combinations ; Fluticasone-Salmeterol Drug Combination ; Humans ; Observation ; Placebos ; Proportional Hazards Models ; Pulmonary Disease, Chronic Obstructive/epidemiology
Czasopismo naukowe
Tytuł:
Comparison of heat-sensitive moxibustion versus fluticasone/salmeterol (seretide) combination in the treatment of chronic persistent asthma: design of a multicenter randomized controlled trial.
Autorzy:
Chen R; The Affiliated Hospital of Jiangxi University of TCM, Nanchang, PR China. />Chen M
Xiong J
Yi F
Chi Z
Zhang B
Pokaż więcej
Źródło:
Trials [Trials] 2010 Dec 15; Vol. 11, pp. 121. Date of Electronic Publication: 2010 Dec 15.
Typ publikacji:
Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Moxibustion*
Research Design*
Albuterol/*analogs & derivatives
Androstadienes/*therapeutic use
Asthma/*therapy
Adolescent ; Adult ; Aged ; Albuterol/therapeutic use ; Chronic Disease ; Clinical Protocols ; Drug Combinations ; Fluticasone-Salmeterol Drug Combination ; Humans ; Middle Aged ; Sample Size
Czasopismo naukowe
Tytuł:
Suppressive effects of formoterol and salmeterol on eotaxin-1 in bronchial epithelial cells.
Autorzy:
Chu YT; Department of Pediatrics, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Chang TT
Jong YJ
Kuo PL
Lee HM
Lee MS
Chang HW
Hung CH
Pokaż więcej
Źródło:
Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology [Pediatr Allergy Immunol] 2010 Mar; Vol. 21 (2 Pt 1), pp. 345-52. Date of Electronic Publication: 2009 Dec 07.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Adrenergic beta-Agonists/*pharmacology
Albuterol/*analogs & derivatives
Anti-Asthmatic Agents/*pharmacology
Bronchi/*drug effects
Chemokine CCL11/*metabolism
Ethanolamines/*pharmacology
Albuterol/pharmacology ; Bronchi/metabolism ; Cell Line ; Chemokine CCL11/analysis ; Colforsin/pharmacology ; Formoterol Fumarate ; Humans ; Interleukin-4/pharmacology ; Propanolamines/pharmacology ; Respiratory Mucosa/drug effects ; Respiratory Mucosa/metabolism ; STAT6 Transcription Factor/analysis ; STAT6 Transcription Factor/metabolism ; Salmeterol Xinafoate
Czasopismo naukowe
Tytuł:
Childhood evaluation of salmeterol tolerance--a double-blind randomized controlled trial.
Autorzy:
Carroll WD; Derbyshire Children's Hospital, Mickleover, Derby, UK.
Jones PW
Boit P
Clayton S
Cliff I
Lenney W
Pokaż więcej
Źródło:
Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology [Pediatr Allergy Immunol] 2010 Mar; Vol. 21 (2 Pt 1), pp. 336-44. Date of Electronic Publication: 2009 Aug 27.
Typ publikacji:
Journal Article; Randomized Controlled Trial
MeSH Terms:
Tachyphylaxis*
Adrenergic beta-Agonists/*therapeutic use
Albuterol/*analogs & derivatives
Anti-Asthmatic Agents/*therapeutic use
Asthma/*drug therapy
Adrenergic beta-Agonists/adverse effects ; Albuterol/adverse effects ; Albuterol/therapeutic use ; Androstadienes/therapeutic use ; Anti-Asthmatic Agents/adverse effects ; Beclomethasone/therapeutic use ; Child ; Female ; Fluticasone ; Forced Expiratory Volume/drug effects ; Humans ; Male ; Salmeterol Xinafoate ; Treatment Outcome
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies